Marine Drugs (Nov 2021)

Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by <i>Karenia</i> spp. and Their Metabolic Products in Marine Organisms

  • Vincent Hort,
  • Eric Abadie,
  • Nathalie Arnich,
  • Marie-Yasmine Dechraoui Bottein,
  • Zouher Amzil

DOI
https://doi.org/10.3390/md19120656
Journal volume & issue
Vol. 19, no. 12
p. 656

Abstract

Read online

In recent decades, more than 130 potentially toxic metabolites originating from dinoflagellate species belonging to the genus Karenia or metabolized by marine organisms have been described. These metabolites include the well-known and large group of brevetoxins (BTXs), responsible for foodborne neurotoxic shellfish poisoning (NSP) and airborne respiratory symptoms in humans. Karenia spp. also produce brevenal, brevisamide and metabolites belonging to the hemi-brevetoxin, brevisin, tamulamide, gymnocin, gymnodimine, brevisulcenal and brevisulcatic acid groups. In this review, we summarize the available knowledge in the literature since 1977 on these various identified metabolites, whether they are produced directly by the producer organisms or biotransformed in marine organisms. Their structures and physicochemical properties are presented and discussed. Among future avenues of research, we highlight the need for more toxin occurrence data with analytical techniques, which can specifically determine the analogs present in samples. New metabolites have yet to be fully described, especially the groups of metabolites discovered in the last two decades (e.g tamulamides). Lastly, this work clarifies the different nomenclatures used in the literature and should help to harmonize practices in the future.

Keywords